(Q83139326)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Pramipexole versus sertraline in the treatment of depression in Parkinson's disease: a national multicenter parallel-group randomized study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

7

Mario Zappia

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

5

Letterio Morgante

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

author name string

Paolo Barone

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Leonardo Scarzella

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Roberto Marconi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Fulvio Bracco

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Bruno Musch

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Depression/Parkinson Italian Study Group

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

publication date

20 April 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

253

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

601-607

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16607468%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-006-0067-5

19 January 2020

exact match

0 references

cites work

Parkinsonism: onset, progression, and mortality

1 reference

12 December 2020

Do serotonin reuptake inhibitor antidepressants worsen Parkinson's disease? A retrospective case series

1 reference

12 December 2020

Pramipexole for bipolar II depression: a placebo-controlled proof of concept study

1 reference

12 December 2020

SSRIs do not worsen Parkinson's disease: evidence from an open-label, prospective study.

1 reference

12 December 2020

Is dopamine implicated in the antidepressant-like effects of selective serotonin reuptake inhibitors in the mouse forced swimming test?

1 reference

12 December 2020

Pramipexole vs levodopa as initial treatment for Parkinson disease: A randomized controlled trial. Parkinson Study Group.

1 reference

12 December 2020

The relevance of the Lewy body to the pathogenesis of idiopathic Parkinson's disease

1 reference

12 December 2020

Antidepressant studies in Parkinson's disease: a review and meta-analysis

1 reference

12 December 2020

Sertraline for the treatment of depression in Parkinson's disease.

1 reference

12 December 2020

The MOS 36-ltem Short-Form Health Survey (SF-36)

1 reference

12 December 2020

Dopamine agonists, receptor selectivity and dyskinesia induction in Parkinson's disease

1 reference

12 December 2020

Factors impacting on quality of life in Parkinson's disease: results from an international survey.

1 reference

12 December 2020

Comparison of pramipexole, fluoxetine, and placebo in patients with major depression

1 reference

12 December 2020

The placebo effect in neurological disorders.

1 reference

12 December 2020

Preliminary randomized, double-blind, placebo-controlled trial of pramipexole added to mood stabilizers for treatment-resistant bipolar depression

1 reference

12 December 2020

Tolerability of paroxetine in Parkinson's disease: A prospective study

1 reference

12 December 2020

Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study.

1 reference

12 December 2020

Clinical evaluation of pramipexole in advanced Parkinson's disease: results of a double-blind, placebo-controlled, parallel-group study

1 reference

12 December 2020

Anhedonia, depression, and motor functioning in Parkinson's disease during treatment with pramipexole

1 reference

12 December 2020

A SELF-RATING DEPRESSION SCALE

1 reference

12 December 2020

Mood changes and "on-off" phenomena in Parkinson's disease.

1 reference

12 December 2020

Paroxetine in Parkinson's disease: effects on motor and depressive symptoms

1 reference

12 December 2020

A rating scale for depression

1 reference

12 December 2020

Clinical Features and Comorbidity of Mood Fluctuations in Parkinson's Disease

1 reference

12 December 2020

Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group

1 reference

12 December 2020